4-Fluoro-3-nitrophenol | CAS:2105-96-6

We serve 4-Fluoro-3-nitrophenol CAS:2105-96-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-Fluoro-3-nitrophenol

Chemical Name:4-Fluoro-3-nitrophenol
CAS.NO:2105-96-6
Synonyms:4-Fluoro-3-nitrophenol
3-nitro-4-fluorophenol
 
Physical and Chemical Properties:
Density 1.5±0.1 g/cm3
Boiling Point 304.9±27.0 °C at 760 mmHg
Melting Point 78-81ºC
Molecular Formula C6H4FNO3
Molecular Weight 157.099
Flash Point 138.2±23.7 °C
Vapour Pressure 0.0±0.7 mmHg at 25°C
Index of Refraction 1.582
 
Specification:
Appearance:Yellow crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 4-Fluoro-3-nitrophenol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-nitro-4-fluorophenol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-nitro-4-fluorophenol Use and application,3-nitro-4-fluorophenol technical grade,usp/ep/jp grade.


Related News: Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector.CHLOROMETHYL(METHYL)DIMETHOXYSILANE manufacturer He was the partner of a 38-year-old Chinese woman who was travelling with him. She was the first confirmed case reported in the Philippines.(4S)-4-(Phenylthio)-L-proline Hydrochloride supplier Chinese President Xi Jinping vowed to tackle the spread of the virus, saying: “People’s lives and health should be given top priority and the spread of the outbreak should be resolutely curbed.”11,11-Dimethyl-5,11-dihydroindeno[1,2-b]carbazole vendor The CTSuccess service uses Catalent’s proprietary StartScoreTM evaluation tool to calculate the complexity of a potential clinical project across more than a dozen specific and objective study characteristics.As the global generic drug market booms and the international API industry accelerates its transfer to developing countries, China and India rely on cost advantages to rapidly grow into major API producers and exporters.